<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Even number, medium chain <z:chebi fb="0" ids="35692">dicarboxylic acids</z:chebi> (<z:mp ids='MP_0000273'>DAs</z:mp>), naturally occurring in high plants, are a promising alternative energy substrate </plain></SENT>
<SENT sid="1" pm="."><plain>Contrary to the homologous fatty acids, <z:mp ids='MP_0000273'>DAs</z:mp> are soluble in water as salts </plain></SENT>
<SENT sid="2" pm="."><plain>They are β-oxidized providing <z:chebi fb="0" ids="15351">Acetyl-CoAs</z:chebi> and <z:chebi fb="0" ids="15380">Succinyl-CoA</z:chebi>, this latter an intermediate of the <z:chebi fb="0" ids="27093">tricarboxylic acid</z:chebi> cycle </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="41865">Sebacic acid</z:chebi> and <z:chebi fb="0" ids="4676">dodecanedioic acid</z:chebi>, <z:mp ids='MP_0000273'>DAs</z:mp> with 10 and 12 carbon atoms respectively, provide 6.6 kcal/g and 7.2 kcal/g each; therefore, their energy density is intermediate between <z:chebi fb="105" ids="17234">glucose</z:chebi> and fatty acids </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0000273'>DAs</z:mp> have been proved to be safe in both experimental animal and humans and their use has been recently proposed in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Studies in animals and humans with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> showed that oral administration of <z:chebi fb="0" ids="41865">sebacic acid</z:chebi> improved glycaemic control, probably by enhancing insulin sensitivity, and reduced hepatic gluconeogenesis and <z:chebi fb="105" ids="17234">glucose</z:chebi> output </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, <z:chebi fb="0" ids="4676">dodecanedioic acid</z:chebi> intake reduced <z:mp ids='MP_0003646'>muscle fatigue</z:mp> during exercise in type-2 <z:mp ids='MP_0002055'>diabetes</z:mp> subjects, suggesting an improvement of energy utilization and "metabolic flexibility" </plain></SENT>
<SENT sid="7" pm="."><plain>In this article we will review the natural sources of <z:mp ids='MP_0000273'>DAs</z:mp>, their fate in animals and humans and their effect in improving <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>. © 2012 The Authors </plain></SENT>
<SENT sid="8" pm="."><plain>British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society </plain></SENT>
</text></document>